Stop Chinese Fentanyl Act of 2025

The Stop Chinese Fentanyl Act of 2025 is a congressional measure aimed at tightening the United States’ response to illicit fentanyl and its precursor chemicals that originate in China. The bill would expand who can be designated as a foreign opioid trafficker to include Chinese entities and senior Chinese officials that produce, distribute, or knowingly facilitate opioid trafficking or fail to take credible steps to prevent it. It would raise penalties for designated traffickers (increasing potential sanctions or other consequences from five to ten years in some cases) and would broaden the reach of sanctions under the Fentanyl Sanctions Act to cover more Chinese actors, including heads of key Chinese regulatory and law enforcement agencies. The bill also adds oversight provisions under the International Emergency Economic Powers Act (IEEPA) and the Trading with the Enemy Act, requiring periodic evaluations, annual congressional reporting, and cost-benefit analyses for regulations tied to any national emergency declared over international drug trafficking. Finally, it clarifies that the act’s authorities are not intended to sanction the importation of goods and urges China to adopt stronger precursor controls, better labeling, and know-your-customer procedures. In short, the act seeks to hold Chinese producers and policymakers more accountable for illicit fentanyl trafficking, escalate potential consequences for those involved, increase congressional oversight, and press China to tighten chemical precursor controls and export/import safeguards. It is currently introduced and referred to Senate committee, with House passage noted in the text.